Emphysema News and Research

Latest Emphysema News and Research

Uncontrolled lung diseases could lead to costly A&E visits and hospital stays

People with potentially fatal chronic lung diseases are not in control of their condition,new research by Chiesi reveals today. This could be leading to costly A&E visits and hospital stays which may be dramatically reduced if they were being treated adequately.

21 Nov 2017

ATS debuts new video to highlight dangers of flavored tobacco

Educating the public about the dangers of tobacco addiction has long been a priority for the American Thoracic Society, which provides scientifically-supported arguments to counter Big Tobacco's marketing and lobbying efforts.

16 Nov 2017

Pollutant from forest and crop fires induces genetic damage in human lung cells

When exposed in a laboratory to pollution levels comparable to those found in the atmosphere of the Amazon region during the forest and crop burning season, human lung cells suffer severe DNA damage and stop dividing. After 72 hours of exposure, over 30% of the cultured cells are dead.

24 Oct 2017

Pharmacological stimulation of nicotinic receptor could be strategy to treat lung inflammation

It has been amply proven that smoking can cause serious diseases such as emphysema and cancer. A new study, however, shows that pharmacological stimulation of a specific type of nicotinic receptor in cells of the immune system could be a strategy to treat inflammatory lung disease.

20 Oct 2017

Self-management program with customized action plan results in better outcomes for COPD patients

The University of Twente carried out the first study worldwide that shows patients with COPD (lung disease caused by smoking) and other illnesses (heart disease, diabetes, anxiety and depression) have better outcomes if they follow a self-management program with a customized action plan. Anke Lenferink of UT recently obtained a doctoral degree on this subject.

27 Sep 2017

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in the New England Journal of Medicine.

12 Sep 2017

People with severe emphysema may breathe better after EBV therapy, study shows

People with severe emphysema may breathe better after a minimally invasive procedure that places valves in the airways leading to diseased portions of their lungs, according to a randomized, controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

12 Sep 2017

New Global Burden of Disease study estimates vast impact of asthma and COPD

Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.

18 Aug 2017

University of Birmingham secures NIHR funding to launch Global Health Research Group

The University of Birmingham has secured £2 million from the National Institute for Health Research to launch a research group aimed at improving healthcare for patients with lung diseases around the world.

14 Jul 2017

COPD can result in structural changes that affect the lung and microbiome

Chronic obstructive pulmonary disease (COPD) can result in structural changes within the lungs over time.

14 Jul 2017

Cigarette smoking causes diverse harm that extends way beyond the lungs

Warning: Cigarette smoking presents far more health hazards than you probably realize.

14 Jun 2017

Researchers use artificial intelligence to predict patient's lifespan

A computer's ability to predict a patient's lifespan simply by looking at images of their organs is a step closer to becoming a reality, thanks to new research led by the University of Adelaide.

1 Jun 2017

FDA issues Complete Response Letter for Sunovion’s New Drug Application to treat COPD patients

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter for the New Drug Application for SUN-101/eFlow (glycopyrrolate) for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema

27 May 2017

Zephyr Endobronchial Valves demonstrate clinical efficacy in heterogeneous and homogenous emphysema patients

Pulmonx, Inc. today announced the results of two multi-center, randomized clinical trials showing clinically meaningful improvements in lung function after treatment with the Zephyr Endobronchial Valve (EBV) in emphysema patients without collateral ventilation.

25 May 2017

CT-measured vascular pruning linked to mortality risk in smokers without COPD

In a new study, CT-measured vascular pruning – the diminution of distal pulmonary blood vessels (vessels on the outer edges of the lungs) – was associated with increased risk of death in smokers without chronic obstructive pulmonary disease.

23 May 2017

Scientists create graphene-based sensor to predict onset of asthma attacks

Rutgers University-New Brunswick scientists have created a graphene-based sensor that could lead to earlier detection of looming asthma attacks and improve the management of asthma and other respiratory diseases, preventing hospitalizations and deaths.

22 May 2017

Smokers with diminished chest muscle may face greater mortality risk, research shows

Smokers with diminished chest muscle may face a greater risk of death than those smokers with more chest muscle, whether they have chronic obstructive pulmonary disease (COPD) or not, according to new research presented at the ATS 2017 International Conference.

22 May 2017

Emphysema News and Research

Latest Emphysema News and Research

Uncontrolled lung diseases could lead to costly A&E visits and hospital stays

ATS debuts new video to highlight dangers of flavored tobacco

Pollutant from forest and crop fires induces genetic damage in human lung cells

Pharmacological stimulation of nicotinic receptor could be strategy to treat lung inflammation

Self-management program with customized action plan results in better outcomes for COPD patients

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

People with severe emphysema may breathe better after EBV therapy, study shows

New Global Burden of Disease study estimates vast impact of asthma and COPD

University of Birmingham secures NIHR funding to launch Global Health Research Group

COPD can result in structural changes that affect the lung and microbiome

Cigarette smoking causes diverse harm that extends way beyond the lungs

Researchers use artificial intelligence to predict patient's lifespan

FDA issues Complete Response Letter for Sunovion’s New Drug Application to treat COPD patients

Zephyr Endobronchial Valves demonstrate clinical efficacy in heterogeneous and homogenous emphysema patients

CT-measured vascular pruning linked to mortality risk in smokers without COPD

Scientists create graphene-based sensor to predict onset of asthma attacks

Smokers with diminished chest muscle may face greater mortality risk, research shows

Clinical trial offers new hope for patients suffering from severe lung disease

Anti-smoking drug safe for COPD patients, research suggests

Clemson University researcher receives NIH grant to advance study into abdominal aortic aneurysms

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Emphysema News and Research

Latest Emphysema News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in